BD Plans To Spin Off Diabetes Care Business
Executive Summary
BD believes the independent new company will create shareholder value and is part of the BD 2025 growth strategy.
You may also be interested in...
Meet Embecta! Becton Dickinson Completes Diabetes Spin-Off
Becton Dickinson has formally completed the planned spin-off of its diabetes business within the timeframe it projected about a year ago. The new company, called embecta, is one of the largest producers of diabetes injection devices.
Polen: BD Aiming For Higher Growth Spaces And More Tuck-Ins
BD stressed the continued pursuit of an innovation-driven growth strategy as it announced fiscal 2021 sales of $20bn spurred by its pandemic response effort.
Exec Chat: Israel’s Authority On Medical Robotics Lifts Curtain Behind Technion’s Success Stories
Medtech Insight talked with Moshe Shoham about the innovative technologies behind surgical robotics companies Microbot Medical, XACT Robotics, Tamar Robotics and ForSight Robotics, which were all spun out of his laboratory in Israel.